Jupiter Neurosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Jupiter Neurosciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 45% of its market value (net debt). Lower than 91% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 91%
Sales fell 91% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-91% / +2258%In 3 years sales changed by -91% while total assets changed by +2258%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-1.0×Operating cash was negative last year, while some debt falls due within a year.
Higher than 66% of Healthcare companies in United States.
Cash Cushion Ratio
−45%Debt, after subtracting cash, equals 45% of its market value (net debt).
Lower than 91% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Jupiter Neurosciences, Inc. made a loss over the last year. Jupiter Neurosciences, Inc. owes $1.10 for every $1 it owns. Jupiter Neurosciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossJupiter Neurosciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-9.30Jupiter Neurosciences, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$3 MThe total market value of all of Jupiter Neurosciences, Inc.'s shares at today's price (share price × number of shares), smaller than 95% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeJupiter Neurosciences, Inc.'s net worth is negative ($0 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-1888.7%Jupiter Neurosciences, Inc. lost 1888.7% of its shareholders' money over the last year, lower than almost all Healthcare companies in United States.
Owes vs Owns
1.10×Jupiter Neurosciences, Inc. owes $1.10 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Dividend yield
NoneJupiter Neurosciences, Inc. does not currently pay a dividend.
Profit growth
LossJupiter Neurosciences, Inc. made a loss in each of the last two years.
Profit margin
-39662.8%Jupiter Neurosciences, Inc. lost $39663 for every $100 of revenue.
Interest cover
Not coveredJupiter Neurosciences, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtJupiter Neurosciences, Inc. had $2 M more debt than cash (net debt) at Dec 2025.
Questions
What is Jupiter Neurosciences, Inc.'s return on equity?
Jupiter Neurosciences, Inc. lost 1888.7% of its shareholders' money over the last year, lower than almost all Healthcare companies in United States.
How much does Jupiter Neurosciences, Inc. owe compared with what it owns?
Jupiter Neurosciences, Inc. owes $1.10 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Does Jupiter Neurosciences, Inc. pay a dividend?
No. Jupiter Neurosciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.